Zobrazeno 1 - 10
of 539
pro vyhledávání: '"Claudio, Rapezzi"'
Autor:
Marco Canepa, Vincenzo De Marzo, Pietro Ameri, Roberto Ferrari, Luigi Tavazzi, Claudio Rapezzi, Italo Porto, Aldo Pietro Maggioni
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 3019-3027 (2023)
Abstract Aims This study aimed to determine whether any change occurred over time in level of evidence (LoE) of therapeutic interventions supporting heart failure (HF) and other European Society of Cardiology guideline recommendations. Methods and re
Externí odkaz:
https://doaj.org/article/6996026135914be794abd59e7c9f25e2
Autor:
Anna Cantone, Matteo Serenelli, Federico Sanguettoli, Daniele Maio, Gioele Fabbri, Beatrice Dal Passo, Piergiuseppe Agostoni, Giovanni Grazzi, Gianluca Campo, Claudio Rapezzi
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2740-2744 (2023)
Abstract Background The clinical value of cardiopulmonary exercise testing (CPET) in cardiac amyloidosis (CA) is uncertain. Due to the growing prevalence of the disease and the current availability of disease‐modifying drugs, prognostic stratificat
Externí odkaz:
https://doaj.org/article/edb5185a3af047f8aa536e9f2797be01
Autor:
Dulce Brito (Chair), Fabiano Castro Albrecht, Diego Perez de Arenaza, Nicole Bart, Nathan Better, Isabel Carvajal-Juarez, Isabel Conceição, Thibaud Damy, Sharmila Dorbala, Jean-Christophe Fidalgo, Pablo Garcia-Pavia, Junbo Ge, Julian D. Gillmore, Jacek Grzybowski, Laura Obici, Daniel Piñero, Claudio Rapezzi, Mitsuharu Ueda, Fausto J. Pinto
Publikováno v:
Global Heart, Vol 18, Iss 1, Pp 59-59 (2023)
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transt
Externí odkaz:
https://doaj.org/article/a1f0ff282fae4f62a6cb5dd78cdd1f0c
Autor:
Paolo Tolomeo, Ottavio Zucchetti, Emanuele D'Aniello, Noemi Punzo, Federico Marchini, Luca Di Ienno, Elisabetta Tonet, Rita Pavasini, Claudio Rapezzi, Gianluca Campo, Matteo Serenelli
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 2037-2043 (2022)
Abstract Aims This study aims to investigate the role of echocardiographically determined left ventricular output indices on sacubitril/valsartan titration in a cohort of outpatients with heart failure and reduced ejection fraction (HFrEF). Methods a
Externí odkaz:
https://doaj.org/article/571b559a7519406489ec34bf3d9ca6e9
Autor:
Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt V. Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman, Leslie Amass, the THAOS investigators
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tiss
Externí odkaz:
https://doaj.org/article/9781169f9482467fa0d76aa446549e0d
Autor:
Göbel, Sebastian, Hobohm, Lukas, Desuki, Alexander, Gori, Tommaso, Münzel, Thomas, Claudio, Rapezzi, Wenzel, Philip, Keller, Karsten
Publikováno v:
In European Journal of Internal Medicine August 2022 102:88-96
Autor:
Matteo Bertini, Emanuele D'Aniello, Luca Di Ienno, Federico Gibiino, Guido Tavazzi, Carlo Alberto Volta, Marco Contoli, Alberto Papi, Gianluca Campo, Roberto Ferrari, Claudio Rapezzi
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 263-269 (2022)
Recent data support the existence of a distinctive ‘vascular’ phenotype with the involvement of both pulmonary parenchyma and its circulation in COVID‐19 pneumonia. Its prompt identification is important for the accurate management of COVID‐1
Externí odkaz:
https://doaj.org/article/b585fe9e86074d82826110c0e0d2cf1b
Autor:
Aldostefano Porcari, Linda Pagura, Francesca Longo, Enrico Sfriso, Giulia Barbati, Luigi Murena, Emiliano Longo, Vittorio Ramella, Zoran Marij Arnež, Claudio Rapezzi, Marco Merlo, Gianfranco Sinagra
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 751-760 (2022)
Abstract Aims Carpal tunnel (CT) syndrome is a recognized red‐flag of cardiac amyloidosis (CA) and increased cardiovascular (CV) morbidity. We designed this study to characterize the CV profile of patients with CT syndrome at the time of first surg
Externí odkaz:
https://doaj.org/article/eff48ba46d6e4edf820243f3c29815f4
Autor:
Marianna Farnè, Cristina Balla, Alice Margutti, Rita Selvatici, Martina De Raffele, Assunta Di Domenico, Paola Imbrici, Elia De Maria, Mauro Biffi, Matteo Bertini, Claudio Rapezzi, Alessandra Ferlini, Francesca Gualandi
Publikováno v:
Cardiogenetics, Vol 11, Iss 3, Pp 139-147 (2021)
Brugada syndrome (BrS) is an inherited disorder with high allelic and genetic heterogeneity clinically characterized by typical coved-type ST segment elevation at the electrocardiogram (ECG), which may occur either spontaneously or after provocative
Externí odkaz:
https://doaj.org/article/e17ee66734544e7688e8d7d16268b950
Autor:
Giacomo Tini, Francesco Cappelli, Elena Biagini, Beatrice Musumeci, Marco Merlo, Lia Crotti, Matteo Cameli, Gianluca Di Bella, Alberto Cipriani, Francesca Marzo, Federico Guerra, Cinzia Forleo, Christian Gagliardi, Mattia Zampieri, Samuela Carigi, Pier Filippo Vianello, Giulia Elena Mandoli, Giuseppe Ciliberti, Luca Lichelli, Davide Mariani, Aldostefano Porcari, Domitilla Russo, Roberto Licordari, Alberto Ponziani, Italo Porto, Federico Perfetto, Camillo Autore, Claudio Rapezzi, Giafranco Sinagra, Marco Canepa
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 3369-3374 (2021)
Abstract Aims The use of beta‐blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns of beta‐blocker prescription through a nationwide survey. Methods and results From 11 referral centres, we retrospectively colle
Externí odkaz:
https://doaj.org/article/e17354fbab234649bb0aa43c9fa75769